Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Oct 27, 2014; 6(10): 752-758
Published online Oct 27, 2014. doi: 10.4254/wjh.v6.i10.752
Published online Oct 27, 2014. doi: 10.4254/wjh.v6.i10.752
Figure 1 Cell death with sorafenib.
The effect of varying doses (1, 5 and 10 µmol/L) of SFN on hepatocellular carcinoma cell viability was determined by the MTT assay at 24, 48 and 72 h in (A) Hep3B and (B) Huh7 cells. PARP expression was analyzed by immunoblotting analysis (C). SFN: Sorafenib; RAPA: Rapamycin.
- Citation: Fischer TD, Wang JH, Vlada A, Kim JS, Behrns KE. Role of autophagy in differential sensitivity of hepatocarcinoma cells to sorafenib. World J Hepatol 2014; 6(10): 752-758
- URL: https://www.wjgnet.com/1948-5182/full/v6/i10/752.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i10.752